DE10243730A1 - Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects - Google Patents

Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects Download PDF

Info

Publication number
DE10243730A1
DE10243730A1 DE2002143730 DE10243730A DE10243730A1 DE 10243730 A1 DE10243730 A1 DE 10243730A1 DE 2002143730 DE2002143730 DE 2002143730 DE 10243730 A DE10243730 A DE 10243730A DE 10243730 A1 DE10243730 A1 DE 10243730A1
Authority
DE
Germany
Prior art keywords
seeds
degenerative joint
linum usitatissimum
analgesic
joint disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2002143730
Other languages
German (de)
Inventor
Hubert Wilhelm Prior
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE2002143730 priority Critical patent/DE10243730A1/en
Publication of DE10243730A1 publication Critical patent/DE10243730A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/55Linaceae (Flax family), e.g. Linum

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Use of seeds of Linum usitatissimum, optionally in comminuted form, for preparing an oral pharmaceutical for treatment of degenerative joint disease.

Description

Die Erfindung betrifft die Verwendung von Samen von Linum usitatissimum zur Herstellung von oral verabreichbaren Arzneimitteln in zerkleinerter oder unzerkleinerter Form, die zur Behandlung von degenerativen Gelenkerkrankungen eingesetzt werden.The invention relates to the use of seeds of Linum usitatissimum for the production of orally administrable Medicines in crushed or uncrushed form, which are used for Treatment of degenerative joint diseases can be used.

Der Lein oder Flachs ist eine sehr alte Kulturpflanze, die zur Faser- und Ölgewinnung in fast allen Teilen der Welt kultiviert wird. Die Samen des angebauten Leins sind kleine, braune, flache längliche Samen, die etwa zwischen 5 bis 14 Gew.-% Wasser, 3 bis 6 Gew.-% Pflanzenschleim, der sich bei der Hydrolyserhamnose, Galactose, Arabinose und Xylose ergibt, 30 bis 45 Gew.-% fettes Öl mit einem hohen Anteil an ungesättigten Fettsäuren, etwa 20 Gew.-% Eiweiß, 2 bis 2,5 Gew.-% Saccharose sowie ferner Lecithin, Enzyme wie beispielsweise Lipasen und 3 bis 4 Gew.-% Mineralsubstanzen und außerdem geringe Mengen cyanogene Glykoside enthält. Außerdem enthält Lein verschiedene Phytosterole und deren Glykoside sowie Lignane, also niedermolekulare Naturstoffe, die durch oxidative Kupplung zweier p- Hydroxyphenylpropen-Einheiten entstehen, wobei β, β'-ständige Hydroxygruppen miteinander veretert sein können, so daß Tetrahydrofuranringsysteme resultieren.The flax or flax is a very old cultivated plant used for fiber and oil production in almost all parts the world is cultivated. The seeds of the grown linen are small, brown, flat elongated Seeds containing between 5 to 14% by weight water, 3 to 6% by weight Plant mucus, which is found in hydrolysis hamnose, galactose, Arabinose and xylose give 30 to 45 wt .-% fatty oil with a high proportion of unsaturated fatty acids, about 20% by weight of protein, 2 to 2.5% by weight of sucrose and also lecithin, enzymes such as, for example Lipases and 3 to 4 wt .-% mineral substances and also minor Contains amounts of cyanogenic glycosides. Moreover contains Flax various phytosterols and their glycosides as well as lignans, that is, low-molecular natural products by oxidative coupling two p-hydroxyphenylpropene units arise, with β, β'-hydroxy groups can be cross-linked so that tetrahydrofuran ring systems result.

Es ist bekannt, daß Phytosterole und deren Glykoside antiinflammatorische Eigenschaften haben; des gleichen ist bekannt, daß Lignane, seien sie nun offenkettig oder in Tetrahydrofuranringform, antileukämisch und antineoplastisch wirken.It is known that phytosterols and whose glycosides have anti-inflammatory properties; of The same is known that lignans, be it open chain or in tetrahydrofuran ring form, antileukaemic and act antineoplastic.

Leinsamen wird bereits seit der Antike als Zusatz zu Brot und Backwaren verwendet und wird in der Volksmedizin einerseits äußerlich als Breiumschlag gegen Magen- und Darmkoliken oder Rheumatismus eingesetzt, ebenso äußerlich in der Kosmetik zur Erweichung der Haut. Innerlich werden Leinsamen als mildes Abführmittel sowie aufgrund des Schleimgehaltes als Magenschutzmittel oder bei Halsentzündungen gegeben.Flaxseed has been around since ancient times used as an addition to bread and baked goods and is used in folk medicine on the one hand, externally as a poultice against gastric and intestinal colic or rheumatism used, just as externally in cosmetics to soften the skin. Inside flaxseed as a mild laxative as well as due to the mucus content as a stomach protection or in case of sore throat given.

Die Behandlung von degenerativen Gelenkerkrankungen, also insbesondere Arthrosen, ist bis heute hin ein Problem, da eine kausale Behandlung außer durch chirurgische Maßnahmen nicht möglich ist und daher nur symptomatisch behandelt werden kann. Zur Linderung der zum Teil massiven Schmerzen werden daher in der Regel hochwirksame Schmerzmittel wie ASS, Diclofenac und ähnliche Verbindung verordnet, die aber bei längerer Einnahme ihrerseits wiederum Magenreizungen u.ä. Beschwerden auslösen können.Treatment of degenerative Joint diseases, especially arthrosis, are still present today a problem because of causal treatment other than through surgical measures not possible and can therefore only be treated symptomatically. For relief The sometimes massive pain is therefore usually a highly effective pain reliever like ASS, Diclofenac and similar compound prescribed, but for longer Taking in turn stomach irritation etc. Can trigger complaints.

Es besteht daher noch ein Bedarf nach peroral zu verabreichenden Arzneimitteln zur Behandlung von regenerativen Gelenkerkrankungen, die möglichst nebenwirkungsfrei sind und deren physiologische Unbedenklichkeit auch bei längerer Einnahme gewährleistet ist.There is therefore still a need for orally administered drugs for the treatment of regenerative joint diseases that are as free of side effects as possible and their physiological harmlessness is guaranteed even with longer use is.

Zur Lösung der Aufgabe wird die Verwendung von Samen von Linum usitatissimum zur Herstellung von oral verabreichbaren Arzneimitteln zur Behandlung von degenerativen Gelenkserkrankungen vorgeschlagen.Use will solve the problem of seeds of Linum usitatissimum for the production of orally administrable Medicines to treat degenerative joint diseases proposed.

Völlig überraschend wurde jetzt festgestellt, daß die orale Gabe von Leinsamen auf den Schmerz- und Entzündungszustand von degenerativen Gelenkerkrankungen, insbesondere Arthrosen einen schmerzstillenden und objektiv antünflammatorischen Effekt ausübt. Worauf dieser Effekt beruht, ist bislang ungeklärt, aber es kann vermutet werden, daß der Gehalt an Phytosterolen und Lignanen dabei eine nicht unbedeutende Rolle spielt.Completely surprising it has now been found that the oral administration of flax seeds for pain and inflammation of degenerative joint diseases, especially arthrosis an analgesic and objectively anti-inflammatory Effect. What this effect is based on has not yet been clarified, but it can be assumed that the content on phytosterols and lignans play a not insignificant role plays.

Es liegen in der Zwischenzeit Beobachtungen an Patienten mit beiderseitigern Gonarthrose der Kniegelenke vor, die zum Teil unter heftigen Schmerzen trotz Medikation von Diclofenac o.ä. Präparaten litten.In the meantime there are observations in patients with bilateral osteoarthritis of the knee, which is sometimes in severe pain despite medication with diclofenac etc. Preparations suffered.

Röntgenologisch bzw. kernspinnthomographisch konnten bei den Patienten Kniegelenkbindeschädigungen mit weitgehendem Verlust des Knorpelsaumes, hochgradiger mukoider Degeneration des Innenmeniskus im Vorderhornbereich und einer kommunizierenden Bakerzyste festgestellt werden, so daß alltägliche Aktivitäten und insbesondere sportliche Betätigungen aufgrund der Schwere der Prozesse nicht mehr möglich waren. Es kam bei der geringsten Belastung zu massiven hoch-akuten Reizergüssen, die zum Teil punktiert werden mußten. Der erste Patient aus einer solchen Gruppe, der in Eigenregie Leinsamen zur Behandlung seiner medikamentenbedingten Gastritis eingenommen hatte, bemerkte nicht nur einen Rückgang der Magenschmerzen, sondern auch der Massivschmerzen im Knie. Diese Wirkung trat innerhalb einer Woche und innerhalb von vier Wochen war der Patient nach jahrelangen Beschwerden plötzlich schmerzfrei. Röntgenologische Untersuchungen ergaben, daß keine Reizergüsse und Entzündungen mehr vorhanden waren und daß die bis dahin massiv gereizte Bakerzyste weder im Bild sichtbar noch erfastbar war. Die Beweglichkeit der Knie war wieder vollständig vorhanden.radiologically or magnetic resonance imaging of the knee could damage the patients with extensive loss of the cartilage margin, high grade mucoid Degeneration of the inner meniscus in the front horn area and a communicating one Baker's cyst can be found, so that everyday activities and especially sporting activities were no longer possible due to the severity of the processes. It came at the slightest Exposure to massive, highly acute irritation that partially punctures had to be. The first patient from such a group, the linseed on his own taken for the treatment of his drug-related gastritis not only noticed a decrease in stomach pain, but also the massive pain in the knee. This effect occurred within one week and within four weeks the patient was gone for years Complaints suddenly painless. radiographic Investigations showed that none delightful effusions and inflammation were more present and that the hitherto massively irritated baker's cyst neither visible nor in the picture was tangible. The mobility of the knees was fully restored.

Die regelmäßig einzunehmende Dosis Leinsamen beträgt etwa 1,0 bis 2,0 g/Tag und ist als Dauertherapie angelegt. Der Leinsamen kann in unzerkleinerter oder zerkleinerter Form eingenommen werden und kann in für den Fachmann bekannter Weise als Granulat, als Suspension in wäßrigen Flüssigkeiten wie Wasser, Fruchtsäften u.ä., aber auch in Form von Kapseln oder Tabletten verabreicht werden. Auch eine länger dauernde Medikation ist bei den Patienten stets als nebenwirkungsfrei angegeben worden, was im Hinblick darauf, daß Leinsamen seit Tausenden von Jahren auch als Lebensmittel verwendet wird, zu erwarten war. Falls erforderlich, kann daher die Dosierung in der ersten Phase der Behandlung auch ohne weiteres auf das Doppelte der angegebenen Mengen oder sogar auf ein Mehrfaches erhöht werden.The regular dose of linseed is about 1.0 to 2.0 g / day and is designed as a continuous therapy. The linseed can be taken in uncrushed or shredded form and can be in for the person skilled in the art as granules, as a suspension in aqueous liquids like water, fruit juices etc., but can also be administered in the form of capsules or tablets. Also one longer continuous medication is always free of side effects in patients what has been stated in view of the fact that linseed has been around for thousands years of food use. If necessary, the dosage can therefore be in the first phase of the treatment without further ado double the specified Quantities or even increased to a multiple.

Claims (3)

Verwendung von Samen von Linum usitatissimum in zerkleinerter oder unzerkleinerter Form zur Herstellung von oral verabreichbaren Arzeimitteln zur Behandlung von degenerativen Gelenkerkrankungen.Use of Linum usitatissimum seeds in crushed or uncrushed form for the production of orally administrable drugs for the treatment of degenerative joint diseases. Verwendung nach Anspruch in Mengen von etwa 1,0 bis 2,0 g/d.Use according to claim in amounts of about 1.0 to 2.0 g / d. Verwendung nach Anspruch 1 oder 2 in Form von Granulaten, wäßrigen Suspensionen, Kapseln oder Tabletten.Use according to claim 1 or 2 in the form of granules, aqueous suspensions, Capsules or tablets.
DE2002143730 2002-09-20 2002-09-20 Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects Ceased DE10243730A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE2002143730 DE10243730A1 (en) 2002-09-20 2002-09-20 Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2002143730 DE10243730A1 (en) 2002-09-20 2002-09-20 Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects

Publications (1)

Publication Number Publication Date
DE10243730A1 true DE10243730A1 (en) 2004-04-01

Family

ID=31969320

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2002143730 Ceased DE10243730A1 (en) 2002-09-20 2002-09-20 Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects

Country Status (1)

Country Link
DE (1) DE10243730A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005097150A1 (en) * 2004-04-06 2005-10-20 Larus Helgason Medicament for relief of symptoms of joint disorders and inflammatory conditions
WO2008058897A2 (en) * 2006-11-17 2008-05-22 Nordic Bioscience A/S Diphyllin and other lignans as a medicament for v-atpase mediated disease

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005097150A1 (en) * 2004-04-06 2005-10-20 Larus Helgason Medicament for relief of symptoms of joint disorders and inflammatory conditions
WO2008058897A2 (en) * 2006-11-17 2008-05-22 Nordic Bioscience A/S Diphyllin and other lignans as a medicament for v-atpase mediated disease
WO2008058897A3 (en) * 2006-11-17 2009-03-26 Nordic Bioscience As Diphyllin and other lignans as a medicament for v-atpase mediated disease

Similar Documents

Publication Publication Date Title
DE69912833T2 (en) COMPOSITION CONTAINING SOY PROTEIN, DIET FIBERS AND PHYTOESTROGES AND THEIR USE FOR THE PREVENTION AND / OR TREATMENT OF CARDIOVASCULAR DISEASES
DE60132444T2 (en) TREATING IRRITATION SYNDROME OR DISEASE
EP2224939B1 (en) Preparations with rosehip extracts, and method of producing rosehip extracts
DE60207877T2 (en) Composition containing procyanidins for reducing appetite in mammals
EP2099462B1 (en) Pharmaceutical preparation for the treatment of inflammatory diseases of the urogenital tract
DE4444288A1 (en) Use of frankincense to treat Alzheimer's disease
DE60132008T2 (en) CYTYLMYRISTATE AND CETYLPALMITATE FOR THE TREATMENT OF ECCEMENTS AND / OR PSORIASIS
DE69825279T2 (en) USE OF GLUCOSAMINE AND GLUCOSAMINE DERIVATIVES FOR THE FAST RELIEF OF JUCKREIZ OR LOCALIZED PAIN
DE3348163C2 (en)
EP4289479A2 (en) 1,8-cineole-containing composition, especially in the form of a nutritional supplement
EP2858655A1 (en) Extracts from mother-of-thyme and the use thereof
DE10243730A1 (en) Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects
EP2149378A1 (en) Topical formulations for the symptomatic treatment of musculoskeletal disorders
WO2012130351A1 (en) Composition for use for digestive problems
DE202007008818U1 (en) Composition for the treatment of infections
DE2015877C3 (en) Medicines used to treat prostate hypertrophy
EP4248955A2 (en) Method for the preparation of easily consumable tablets containing ginkgo biloba leaf extract
EP0256353A2 (en) Pharmaceutical therapy against the bad absorption of food or oral drugs
DE102014113770A1 (en) Plaster with oily plant extracts
EP2509613A1 (en) Compound for treating gastrointestinal problems
DE3809427A1 (en) Use of seeds of the neem tree for the prophylaxis and therapy of viral infections
Mohanty et al. A double-blind, placebo-controlled Homoeopathic Pathogenetic Trial of Nanocurcumin 6X
EP4248956A2 (en) Pharmaceutical composition comprising cannabidiol
EP2046135B1 (en) Polyphenol/peptide composition and use thereof for promoting gastric health
WO2016005140A1 (en) Composition for treating stomach pain

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8131 Rejection